Over 150 individuals and organisations celebrated on 2011's Clinical Trials Honour RollOver 150 individuals and organisations are celebrated for their contribution to clinical trials on the 4th Annual Clinical Trials Honour Roll published in celebration of International Clinical Trials Day, 20th May 11.
By: Dr Janelle Bowden By celebrating the diverse efforts of many toward developing better treatments and cures for all, the Clinical Trials Honour Roll aims to demonstrate the value of clinical trials, raise awareness of clinical trials, and let those involved know their contributions are appreciated. It also hopes to inspire others to consider becoming involved in clinical trials in the future. A special note of congratulations goes to Margaret Morton, a research coordinator at The Prince Charles Hospital in Brisbane, Australia, who receives the ARCS Australia sponsored award of Most Nominated Individual in Australia on this year’s Honour Roll. For more information on this event, please visit the website: http://www.ClinicalTrialsHonourRoll.com. Media Contact: Dr Janelle Bowden, Founder of the Clinical Trials Honour Roll through AccessCR Pty Ltd. P: +61 (0)406 952 659 E: Janelle@ Background Information About International Clinical Trials' Day International Clinical Trials' Day was launched by the European Clinical Research Infrastructure Network (http://www.ecrin.org/ On the Value of Clinical Trials Clinical trials are an important step in collecting the evidence for what treatments work, and what don't work. In 2008, more than $35 billion was spent on clinical research of investigational treatments [1]. Yet, the clinical research workforce is under pressure and pessimistic about the future[2] and finding enough volunteers to participate in trials remains a problem [3]. Clinical trials provide doctors the evidence on which to base their decisions about the safety and effectiveness of different treatments. But, developing new medical treatments is a risky, costly affair. Governments, non-profit and for-profit organisations are continually scrutinising the value of the research being conducted, what research should be funded, and where that research should be conducted. Tens of thousands of professionals and organisations worldwide contribute to the infrastructure, funding and running of clinical trials, representing a significant workforce from a variety of science, medical, statistics and related backgrounds, and increasingly marketing, telecommunications and IT industries. Hundreds of thousands of people volunteer to participate in over clinical trials annually, personally reaping the benefits of access to breakthrough treatments early and typically better outcomes as a direct result of the increased medical care and attention they receive, at no cost. Clinical trials also benefit the entire public healthcare system as the costs of treatment for trial volunteers with conditions such as cancer, stroke, heart disease are covered by the clinical trial sponsors. Additionally, the patients of organisations that run clinical trials generally have better outcomes as a result of the culture of improvement that involvement in research develops. References: 1. Sizing up the Clinical Research Market by Kenneth Getz, CentreWatch. Accessed 18Jan11 http://www.centerwatch.com/ 2. Pessimism and Instability Defining the Clinical Research Workforce by Karyn Korieth, CentreWatch. Accessed 18Jan11 http://www.centerwatch.com/ 3. Clinical trial facts and figures - General Patient Recruitment Information, CISCRP. Accessed 18Jan11. http://www.ciscrp.org/ The Clinical Trials Honour Roll Nomination Process Over the past 2 months, everyone from trial volunteers, to researchers, industry professionals, ethics committees, funders and related organisations have had the opportunity to be nominated for their contributions to clinical trials over the past year on the Clinical Trials Honour Roll via completion of an online form, or submission of an excel spreadsheet. All nominations received that demonstrate a contribution to clinical trials are published on the Honour Roll, and all nominees are sent a Certificate of Acknowledgement recognising their nomination for this event. More background to this event is available on the website: www.ClinicalTrialsHonourRoll.com. Financial Sponsors About Nucleus Network Nucleus Network is an Australian headquartered clinical research organisation focussing on the conduct of Phase I/ early phase clinical trials. The organisation employs over 100 people that are passionate about what they do and live by quality and excellence. Nucleus Network has two purpose built State-of-the- About ARCS Australia Ltd ARCS Australia Ltd is the professional development association representing individuals involved in the development of therapeutic products. We are the leading Australian provider of education and information, and a forum for the exchange of ideas. ARCS education and training is available to industry and non-industry personnel, members and non-members. http://www.ARCS.com.au About AccessCR AccessCR is an Australian company founded by Dr Janelle Bowden providing clinical research expertise and advocacy. It provides financial and project management support for the Clinical Trials Honour Roll as part of its mission to increase awareness and understanding of clinical trials, and partnership between all those involved in the clinical trial process. http://www.AccessCR.com.au. AccessCR is grateful to our financial and non-financial sponsors for their contributions toward making the 2011 Honour Roll possible. In Kind Supporters Molecule Contract Research Organisation: ECRIN – European Clinical Research Infrastructure Network: A European network dedicated to improving the health of patients and citizens across the world through clinical research. # # # This unique event celebrates all the volunteers, professionals and organizations that contribute to advancing medicine through their involvement in clinical trials. It aims to raise awareness of and recognise those involved in clinical trials. Photo: https://www.prlog.org/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|